메뉴 건너뛰기
OncoImmunology
Volumn 2, Issue 4, 2013, Pages
Uncovering a novel mechanism whereby NK cells interfere with glioblastoma virotherapy
Author keywords

Brain tumor; Cancer; Glioblastoma; Innate immunity; Oncolytic virus
Indexed keywords

CLODRONIC ACID; CYCLOPHOSPHAMIDE; GAMMA INTERFERON; LIPOSOME; ONCOLYTIC VIRUS;
EID: 84886943428     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onco.23658     Document Type: Article
Times cited : (15)
References (10)
  • 1
    • 67650675099 scopus 로고    scopus 로고
    • Pharmacologic and chemical adjuvants in tumor virotherapy
    • PMID:19462957
    • Alvarez-Breckenridge C, Kaur B, Chiocca EA. Pharmacologic and chemical adjuvants in tumor virotherapy. Chem Rev 2009; 109:3125-40; PMID:19462957; http://dx.doi.org/10.1021/cr900048k
    • (2009) Chem Rev , vol.109 , pp. 3125-3140
    • Alvarez-Breckenridge, C.1    Kaur, B.2    Chiocca, E.A.3
  • 2
    • 84863653214 scopus 로고    scopus 로고
    • Oncolytic virotherapy
    • PMID:22781695
    • Russell SJ, Peng KW, Bell JC. Oncolytic virotherapy. Nat Biotechnol 2012; 30:658-70; PMID:22781695; http://dx.doi.org/10.1038/nbt.2287
    • (2012) Nat Biotechnol , vol.30 , pp. 658-70
    • Russell, S.J.1    Peng, K.W.2    Bell, J.C.3
  • 3
    • 0032814773 scopus 로고    scopus 로고
    • Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses
    • PMID:10426310
    • Ikeda K, Ichikawa T, Wakimoto H, Silver JS, Deisboeck TS, Finkelstein D, et al. Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses. Nat Med 1999; 5:881-7; PMID:10426310; http://dx.doi.org/10.1038/11320
    • (1999) Nat Med , vol.5 , pp. 881-7
    • Ikeda, K.1    Ichikawa, T.2    Wakimoto, H.3    Silver, J.S.4    Deisboeck, T.S.5    Finkelstein, D.6
  • 4
    • 33748088164 scopus 로고    scopus 로고
    • Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses
    • PMID:16908838
    • Fulci G, Breymann L, Gianni D, Kurozomi K, Rhee SS, Yu J, et al. Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses. Proc Natl Acad Sci U S A 2006; 103:12873-8; PMID:16908838; http://dx.doi.org/10.1073/pnas.0605496103
    • (2006) Proc Natl Acad Sci U S A , vol.103 , pp. 12873-12878
    • Fulci, G.1    Breymann, L.2    Gianni, D.3    Kurozomi, K.4    Rhee, S.S.5    Yu, J.6
  • 5
    • 35148871720 scopus 로고    scopus 로고
    • Depletion of peripheral macrophages and brain microglia increases brain tumor titers of oncolytic viruses
    • PMID:17909049
    • Fulci G, Dmitrieva N, Gianni D, Fontana EJ, Pan X, Lu Y, et al. Depletion of peripheral macrophages and brain microglia increases brain tumor titers of oncolytic viruses. Cancer Res 2007; 67:9398-406; PMID:17909049; http://dx.doi.org/10.1158/0008-5472.CAN-07-1063
    • (2007) Cancer Res , vol.67 , pp. 9398-406
    • Fulci, G.1    Dmitrieva, N.2    Gianni, D.3    Fontana, E.J.4    Pan, X.5    Lu, Y.6
  • 6
    • 37549027165 scopus 로고    scopus 로고
    • Exponential enhancement of oncolytic vesicular stomatitis virus potency by vectormediated suppression of inflammatory responses in vivo
    • PMID:18071337
    • Altomonte J, Wu L, Chen L, Meseck M, Ebert O, García-Sastre A, et al. Exponential enhancement of oncolytic vesicular stomatitis virus potency by vectormediated suppression of inflammatory responses in vivo. Mol Ther 2008; 16:146-53; PMID:18071337; http://dx.doi.org/10.1038/sj.mt.6300343
    • (2008) Mol Ther , vol.16 , pp. 146-53
    • Altomonte, J.1    Wu, L.2    Chen, L.3    Meseck, M.4    Ebert, O.5    García-Sastre, A.6
  • 7
    • 60149101705 scopus 로고    scopus 로고
    • Enhanced oncolytic potency of vesicular stomatitis virus through vector-mediated inhibition of NK and NKT cells
    • PMID:18846115
    • Altomonte J, Wu L, Meseck M, Chen L, Ebert O, García-Sastre A, et al. Enhanced oncolytic potency of vesicular stomatitis virus through vector-mediated inhibition of NK and NKT cells. Cancer Gene Ther 2009; 16:266-78; PMID:18846115; http://dx.doi.org/10.1038/cgt.2008.74
    • (2009) Cancer Gene Ther , vol.16 , pp. 266-78
    • Altomonte, J.1    Wu, L.2    Meseck, M.3    Chen, L.4    Ebert, O.5    García-Sastre, A.6
  • 8
    • 70450200778 scopus 로고    scopus 로고
    • The case of oncolytic viruses versus the immune system: waiting on the judgment of Solomon
    • PMID:19630549
    • Prestwich RJ, Errington F, Diaz RM, Pandha HS, Harrington KJ, Melcher AA, et al. The case of oncolytic viruses versus the immune system: waiting on the judgment of Solomon. Hum Gene Ther 2009; 20:1119-32; PMID:19630549; http://dx.doi.org/10.1089/hum.2009.135
    • (2009) Hum Gene Ther , vol.20 , pp. 1119-1132
    • Prestwich, R.J.1    Errington, F.2    Diaz, R.M.3    Pandha, H.S.4    Harrington, K.J.5    Melcher, A.A.6
  • 9
    • 84870909657 scopus 로고    scopus 로고
    • NK cells impede glioblastoma virotherapy through NKp30 and NKp46 natural cytotoxicity receptors
    • PMID:23178246
    • Alvarez-Breckenridge CA, Yu J, Price R, Wojton J, Pradarelli J, Mao H, et al. NK cells impede glioblastoma virotherapy through NKp30 and NKp46 natural cytotoxicity receptors. Nat Med 2012; 18:1827-34; PMID:23178246; http://dx.doi.org/10.1038/nm.3013
    • (2012) Nat Med , vol.18 , pp. 1827-34
    • Alvarez-Breckenridge, C.A.1    Yu, J.2    Price, R.3    Wojton, J.4    Pradarelli, J.5    Mao, H.6
  • 10
    • 33644547005 scopus 로고    scopus 로고
    • Glioma virotherapy: effects of innate immune suppression and increased viral replication capacity
    • PMID:16489036
    • Friedman A, Tian JP, Fulci G, Chiocca EA, Wang J. Glioma virotherapy: effects of innate immune suppression and increased viral replication capacity. Cancer Res 2006; 66:2314-9; PMID:16489036; http://dx.doi.org/10.1158/0008-5472.CAN-05-2661
    • (2006) Cancer Res , vol.66 , pp. 2314-9
    • Friedman, A.1    Tian, J.P.2    Fulci, G.3    Chiocca, E.A.4    Wang, J.5

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.